Obesity represents a major risk factor for the development of hypertension and other cardiovascular disorders, and current therapeutic approaches to prevent and reverse obesity are insufficient. Studies from the NIH and others have demonstrated that human obesity, and resistance to weight loss, is related to the suppression of energy expenditure at rest (termed resting metabolic rate, or RMR). While clinical studies utilizing an array of pharmaceuticals (2,4-dinitrophenol, etc.) have provided proof-of-concept data highlighting the utility of RMR stimulation to reverse obesity, all existing pharmaceuticals that stimulate RMR exhibit unsafe pharmacokinetics and are therefore banned for human use. Development of next-generation therapeutic strategies to combat the obesity epidemic requires increased understanding of the biological controllers of RMR. The hypothalamus, and more specifically the arcuate nucleus (ARC), is critically involved in the integrative control of RMR, and we have recently documented a role for the angiotensin II type 1A (AT1A) receptor, localized to agouti-related peptide (AgRP) neurons of the ARC, in the control of RMR by a diverse array of stimulators including leptin, high fat diet, and the brain renin-angiotensin system (RAS). The objective of the current proposal is to understand the second-messenger signaling cascade within AgRP neurons which is activated by AT1A, and to clarify the neurocircuitry and neurotransmitters which mediate RMR control by the ARC RAS. Based on exciting new unpublished data, we hypothesize that AT1A on AgRP neurons rather uniquely activates a G- alpha-i-2 (GNAI2) cascade, which is sensitive to modulation by regulator of G-protein signaling-2 (RGS2). Further, we hypothesize that this cascade mediates control of AgRP neurotransmission and therefore the activation of melanocortin-mediated signaling through its type-4 receptor (MC4R). Finally, new data support the novel concept that RGS2 also modulates MC4R second-messenger signaling, and is itself regulated by MC4R signaling, which results in an autoregulatory cascade within MC4R neurons that may underlie cardiometabolic sensitization as explored across projects in the current program.

Public Health Relevance

Dysfunctional control of resting metabolic rate is implicated in the pathogenesis and maintenance of obesity, and evidence supports a role of the hypothalamic arcuate nucleus in metabolic rate control. We have demonstrated a critical role for angiotensin receptors, localized to specific neurons of the arcuate nucleus, in the integrative control of resting metabolism. The current project will investigate the neurocircuitry and signaling cascades within the arcuate nucleus that mediate metabolic control by angiotensin, with the ultimate goal of understanding neural control of cardiometabolic function in health and disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
7P01HL084207-12
Application #
9750281
Study Section
Special Emphasis Panel (ZHL1)
Program Officer
Maric-Bilkan, Christine
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
12
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Medical College of Wisconsin
Department
Type
DUNS #
937639060
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Morselli, Lisa L; Claflin, Kristin E; Cui, Huxing et al. (2018) Control of Energy Expenditure by AgRP Neurons of the Arcuate Nucleus: Neurocircuitry, Signaling Pathways, and Angiotensin. Curr Hypertens Rep 20:25
Nair, Anand R; Agbor, Larry N; Mukohda, Masashi et al. (2018) Interference With Endothelial PPAR (Peroxisome Proliferator-Activated Receptor)-? Causes Accelerated Cerebral Vascular Dysfunction in Response to Endogenous Renin-Angiotensin System Activation. Hypertension 72:1227-1235
Seoane-Collazo, Patricia; Roa, Juan; Rial-Pensado, Eva et al. (2018) SF1-Specific AMPK?1 Deletion Protects Against Diet-Induced Obesity. Diabetes 67:2213-2226
Schmidt, Eric A; Despas, Fabien; Pavy-Le Traon, Anne et al. (2018) Intracranial Pressure Is a Determinant of Sympathetic Activity. Front Physiol 9:11
Scroggins, Sabrina M; Santillan, Donna A; Lund, Jenna M et al. (2018) Elevated vasopressin in pregnant mice induces T-helper subset alterations consistent with human preeclampsia. Clin Sci (Lond) 132:419-436
Forrester, Steven J; Booz, George W; Sigmund, Curt D et al. (2018) Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology. Physiol Rev 98:1627-1738
Sandgren, Jeremy A; Linggonegoro, Danny W; Zhang, Shao Yang et al. (2018) Angiotensin AT1A receptors expressed in vasopressin-producing cells of the supraoptic nucleus contribute to osmotic control of vasopressin. Am J Physiol Regul Integr Comp Physiol 314:R770-R780
Pellegrinelli, Vanessa; Peirce, Vivian J; Howard, Laura et al. (2018) Adipocyte-secreted BMP8b mediates adrenergic-induced remodeling of the neuro-vascular network in adipose tissue. Nat Commun 9:4974
Peng, Hua; Jensen, Dane D; Li, Wencheng et al. (2018) Overexpression of the neuronal human (pro)renin receptor mediates angiotensin II-independent blood pressure regulation in the central nervous system. Am J Physiol Heart Circ Physiol 314:H580-H592
Bell, Balyssa B; Harlan, Shannon M; Morgan, Donald A et al. (2018) Differential contribution of POMC and AgRP neurons to the regulation of regional autonomic nerve activity by leptin. Mol Metab 8:1-12

Showing the most recent 10 out of 202 publications